Summary of Results in the year ended 30 June 2012
- Fundraising in April 2012 generated cash of £555,000 before issue expenses.
- The turnover of the Company more than doubled to £135,306 (2011: £53,345).
- The operating loss reduced to £577,922 (2011: £693,795).
- On 30 June 2012 the surplus of shareholders’ funds was £734,570 (2011: £755,511).
With a now fully validated Virtual Tumour technology, Physiomics has concentrated its efforts on product extension, new product development and increasing the customer base. Read more